Sub-Q Bionics

Sub-Q Bionics is a medical technology company focused on revolutionizing the administration of large-volume biologics through its proprietary subcutaneous delivery platform. The company's technology is designed to enable the rapid, high-volume injection of therapeutics that currently require lengthy intravenous infusions, such as monoclonal antibodies for oncology and autoimmune diseases. By facilitating subcutaneous delivery of 10 mL or more in minutes, Sub-Q Bionics aims to shift care from clinical settings to the home, enhancing patient quality of life and reducing systemic healthcare burdens. The platform is engineered to handle high-viscosity formulations, addressing a significant bottleneck in the delivery of next-generation biologics.